September 2022

NEWS & COLUMNS

6-7 NEWS
Merck and Orna agree on deal worth $3.5bn; Novartis to create standalone company for Sandoz

8-9 NEWS
MHRA approves Novartis’ Pluvicto; Parkinson's UK partners with Parkinson's Foundation

10-11 CORONAVIRUS NEWS
JCVI publishes advice for autumn booster campaign; Valneva's COVID-19 vaccine approved by WHO

12 DARWIN'S MEDICINE
Longevity lessons

13 POLICY AND PUBLIC HEALTH
The Holy Grail of healthcare pricing 

14 FIRST RESPONSE
How can we support our health services?

16 PHARMA STRATEGIST'S BLOG
Agile strategy or strategy for 'Agile'?

FEATURES

18-19 THE FIGHT AGAINST AMR
Using the latest technologies as standard to support healthcare services, such as GP practices and pharmacies, against future health crises

22-23 AI AND RARE DISEASES
There are over 7,000 known rare diseases, with over 3.5 million people in the UK living with a rare disease and as many as one in 15 people worldwide

24-25 PANDEMIC PREPAREDNESS 
With the threat of global pandemics in the future a certainty, not a question, how can pharma supply chains be better supported?

26-27 A HEALTHIER EVERYDAY FOR WOMEN
Placing women's health at the heart of the conversation, after these health issues have been overlooked and deprioritised for decades